The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001775:Blood Circulation / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000494:pharmacology*; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects*; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010710:Phosphates / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D010759:Phosphorus Isotopes; D010830:Physostigmine / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000097:blood / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D010710:Phosphates; D010759:Phosphorus Isotopes; D011220:Pralidoxime Compounds; D007531:Isoflurophate; D001285:Atropine; D010830:Physostigmine; D000251:Adenosine Triphosphatases